Skip to Main Content

Paper Details

Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease.
Eye Contact Lens
13
2017

Datasets